ELIDEL / pharyngitis

United States · event evidence

pharyngitis

Listed

Increased over vehicle in the 1-year safety study.

Authority: DailyMed, U.S. National Library of Medicine
Document: ELIDEL (PIMECROLIMUS) CREAM [PHYSICIANS TOTAL CARE, INC.]
Jurisdiction: United States
Version / revision: 1
Document date: Not recorded
Source: Official source document

Source evidence

Nasopharyngitis (26% vs. 21%), influenza (13% vs. 4%), pharyngitis (8% vs. 3%), viral infection (7% vs. 1%), pyrexia (13% vs. 5%), cough (16% vs. 11%), and headache (25% vs. 16%) were increased over vehicle in the 1-year safety study (see ADVERSE REACTIONS).

Section: Not stated
Context: Increased over vehicle in the 1-year safety study.
Frequency: Not stated
Population / denominator: Not stated

Return to label evidence explorer